Evidence map›Paper›PMID 33585078›Full record

ArticlePeerJ2021

The long non-coding RNA GHSROS reprograms prostate cancer cell lines toward a more aggressive phenotype.

Patrick B Thomas, Penny Jeffery, Manuel D Gahete, Eliza Whiteside, Carina Walpole, Michelle Maugham, Lidija Jovanovic, Jennifer Gunter, Elizabeth Williams, Colleen Nelson and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PeerJ, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 3 countries.

Patrick B ThomasGhrelin Research Group, Translational Research Institute, School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
Penny JefferyGhrelin Research Group, Translational Research Institute, School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
Manuel D GaheteMaimonides Institute of Biomedical Research of Cordoba (IMIBIC), Cordoba, Spain.
Eliza WhitesideCentre for Health Research, University of Southern Queensland, Toowoomba, Queensland, Australia.
Carina WalpoleGhrelin Research Group, Translational Research Institute, School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
Michelle MaughamGhrelin Research Group, Translational Research Institute, School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
Lidija JovanovicAustralian Prostate Cancer Research Centre - Queensland, Queensland University of Technology, Brisbane, Queensland, Australia.
Jennifer GunterAustralian Prostate Cancer Research Centre - Queensland, Queensland University of Technology, Brisbane, Queensland, Australia.
Elizabeth WilliamsAustralian Prostate Cancer Research Centre - Queensland, Queensland University of Technology, Brisbane, Queensland, Australia.
Colleen NelsonAustralian Prostate Cancer Research Centre - Queensland, Queensland University of Technology, Brisbane, Queensland, Australia.
Adrian HeringtonGhrelin Research Group, Translational Research Institute, School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
Raul M LuqueMaimonides Institute of Biomedical Research of Cordoba (IMIBIC), Cordoba, Spain.
Rakesh VeeduCentre for Comparative Genomics, Murdoch University, Perth, Western Australia, Australia.
Lisa K ChopinGhrelin Research Group, Translational Research Institute, School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
Inge SeimGhrelin Research Group, Translational Research Institute, School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
Queensland University of Technology · AUHospital Universitario Reina Sofía · ESMurdoch University · AUNanjing Normal University · CNTranslational Research Institute · AUUniversity of Córdoba · ESUniversity of Southern Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is now appreciated that long non-coding RNAs (lncRNAs) are important players in orchestrating cancer progression. In this study we characterized

Indexed as

Antisense transcriptGene expressionlncRNALong non-coding RNAProstate cancerTumour growth

Identifiers

PMID33585078
PMCPMC7860111
OpenAlexW3127390058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.